Edition:
United Kingdom

New Century Healthcare Holding Co Ltd (1518.HK)

1518.HK on Hong Kong Stock

6.39HKD
3:15am BST
Change (% chg)

HK$0.20 (+3.23%)
Prev Close
HK$6.19
Open
HK$6.20
Day's High
HK$6.41
Day's Low
HK$6.20
Volume
22,500
Avg. Vol
189,780
52-wk High
HK$23.00
52-wk Low
HK$6.02

Summary

Name Age Since Current Position

Jason Zhou

52 2015 Executive Chairman of the Board, Chief Executive Officer

Han Xu

45 2016 Chief Financial Officer, Vice President, Executive Director

Hong Xin

47 2016 Chief Operating Officer, Vice President, Executive Director

Hong Zhou

57 2016 Vice President and Chief Medical Officer of the Group

Lan Teng

41 2016 Director - Human Resources

Xiaofeng Jia

37 Joint Company Secretary, Assistant to the Chief Executive Officer and the Chairman of the Group and the Investment Director of the Group

Lai Shan So

2018 Joint Company Secretary

Qizhi Guo

45 2018 Non-Executive Director

Yanqing Liang

44 2016 Non-Executive Director

Siye Wang

35 2016 Non-Executive Director

Lan Zhang

38 2016 Non-Executive Director

Yanfu Jiang

73 2016 Non-Executive Independent Director

Jing Ma

55 2016 Non-Executive Independent Director

Hongbin Sun

42 2016 Non-Executive Independent Director

Guanxiong Wu

44 2016 Non-Executive Independent Director

Biographies

Name Description

Jason Zhou

Mr. Jason Zhou serves as Executive Chairman of the Board, Chief Executive Officer of the Company. He is the founder of our Group, a Controlling Shareholder and has been an executive Director, the Chief Executive Officer and the Chairman of our Group since August 2015. Since Mr. Zhou founded our Group in 2002, he has been leading our Group for over 13 years to serve in the private healthcare industry. Mr. Zhou has been the driving force behind our development, growth and expansion and is primarily responsible for the overall management of our Group and directing the strategic development and business plans of our Group. Mr. Zhou is currently a director of several of our principal operating subsidiaries. From April 2001 to December 2002, Mr. Zhou served as the general manager of Beijing Chuangju Science and Technological Development Co., Ltd., where he was responsible for sales of telecommunications equipment, software and related services to major telecommunications companies in the PRC. Prior to that, Mr. Zhou served as the general manager of Beijing Chuangju Telecommunications Technology Co., Ltd. Between March 1991 and December 1995, Mr. Zhou served as the general manager of Guanglian Industrial (Group) Co., Ltd Between July 1987 and August 1990, Mr. Zhou was an engineer at the Beijing Central Engineering and Research Incorporation of Iron and Steel Industry Mr. Zhou obtained his bachelor’s degree in Electrical Engineering from Beijing Union University in July 1987.

Han Xu

Mr. Xu Han serves as Chief Financial Officer, Vice President, Executive Director of the Company. He joined our Group in October 2005 and has been an executive Director since February 2016. In April 2016, he was appointed as Vice President of the Group. Mr. Xu serves as the Group’s Chief Financial Officer, with overall responsibility for the financial management of each member of the Group and the Group’s investment and financing activities, as well as overseeing the Group’s internal controls and information technology. Prior to joining our Group, Mr. Xu served as the group chief financial officer of United Family Healthcare Group between July 2003 and September 2005, with primary responsibility for financial management of the hospitals and clinics in its Beijing and Shanghai network. Mr. Xu held the position of senior financial analyst at Intel (China) Co., Ltd. from December 2000 to May 2001. Between July 2001 and June 2003, Mr. Xu held the role of senior finance manager of Beijing Powerise Technology Co., Ltd., a subsidiary of Shenzhen Stock Exchange-Listed Powerise Information Technology Co., Ltd. Mr. Xu was also a financial analyst at China Hewlett Packard Co., Ltd from October 1997 to October 2000. Mr. Xu served as a senior financial analyst in the consulting arm of Deloitte in Beijing from August 1996 to October 1997. Between August 1994 and July 1996, Mr. Xu worked in the finance department of China International Telecommunication Construction Corporation in Beijing. Mr. Xu obtained his bachelor’s degree in Economics from the Harbin Institute of Technology in July 1994.

Hong Xin

Ms. Xin Hong serves as Chief Operating Officer, Vice President, Executive Director of the Company. She has been an executive Director since February 2016. In April 2016, she was also appointed as Vice President and Chief Operating Officer of the Group. She is primarily responsible for overseeing the management and operation of the Group’s hospitals and overall business, including assisting in obtaining relevant regulatory approvals, as well as being involved in the design and construction of the Group’s hospitals, the Group’s decision making processes and organizational structure, and the management of day to day operations. Ms. Xin has been the chief operating officer and project director of BNC Children’s Hospital following its establishment in December 2002, being primarily responsible for the preparation of the hospital’s projects, commercial negotiations on behalf of the hospital, market development and the implementation of international best practice standards in the Group’s hospitals. Ms. Xin has more than 14 years of experience in hospital operations management and took up a number of positions in our Group throughout her current tenure. Ms. Xin has represented the Group in international medical exchanges and its participation in international and regional health organizations. Ms. Xin is a guest lecturer on hospital management at Peking University, and has on several occasions addressed the general assembly at the annual meeting of China’s private hospitals. From July 1990 to July 2001, Ms. Xin held the role of a sales manager at Jianguo Hotel Beijing. In June 2015, Ms. Xin was elected as a member of the Standing Committee of the Private Hospital Management Branch of the Chinese Hospital Association. Ms. Xin obtained a college degree in English from Beijing Institute of Aeronautics, Beijing (presently known as Beihang University) in July 1990.

Hong Zhou

Ms. Zhou Hong serves as Vice President and Chief Medical Officer of the Group of the Company. She is a chief physician, is the Vice President and the Chief Medical Officer of our Group with overall responsibility for the medical department of the Group’s hospitals, including overseeing the overall management of our healthcare services and our professional team and the professional training, and assisting with the development of the Group’s business, annual plans and strategic business plans. She is also involved in cultivating relationships between our Group and the medical community as well as the marketing and public relations activities of our Group. Ms. Zhou joined our Group in March 2005, initially as a medical director of BNC Children’s Hospital. Prior to joining our Group, Ms. Zhou had been involved in the field of child surgery clinical work for 22 years. Between September 1983 and September 2001, Ms. Zhou served at BCH, holding a number of roles including director of the surgery department. Ms. Zhou has also taught at the Capital University of Medical Sciences in Beijing as an associate professor from September 2000 to November 2003, a professor from November 2003 to February 2014. Ms. Zhou is (i) a member of the Pediatric Nutrition Support Group of the Fourth Committee of the Parenteral and Enteral Nutrition Society, the Chinese Medical Association, and (ii) a vice director of the Pediatric Committee of the Beijing Medical Women’s Association. Ms. Zhou is also on the editorial board of the Chinese Journal for Clinicians. Ms. Zhou obtained her bachelor’s degree in pediatrics from the Capital University of Medical Sciences in Beijing in August 1983.

Lan Teng

Ms. Teng Lan serves as Director - Human Resources of the Group of the Company. He has been the Director of Human Resources for BNC Children’s Hospital since April 2016. Ms. Teng’s primary responsibilities include managing the Group’s human resources and affairs, overseeing the recruitment, and assisting with the training of medical services personnel, auditing staff budgets and strategic planning for senior personnel. Ms. Teng joined our Group in February 2006 as the Director of Human Resources of BNC Children’s Hospital and since then has assumed various managerial positions, including clinic manager and the director of operations. Ms. Teng has nearly 20 years of experience in human resources management, including more than 15 years in the medical industry. Prior to joining our Group, Ms. Teng had served as the manager of government relations at Hua Mei Kang Medical Consultancy Management (Beijing) Limited between March 2005 and January 2006, an assistant general manager at Shenzhen Shenyun Trading Enterprise Co. Limited between June 2004 and December 2004, a human resources manager at Beijing United Family Hospital from November 2000 to June 2004, a human resources director at Kerry Hotel Beijing from February 1999 to November 2000, and a human resources assistant at Beijing ATV Jinlang Hotel from July 1997 to February 1999. Ms. Teng obtained her bachelor’s degree in economics from the Beijing University of Technology in July 1997. Ms. Teng also obtained her certificate in senior human resources management from Tsinghua University’s School of Economics and Management in November 2015, and her certificate of completion in Applied Psychology from Peking University’s Department of Psychology in December 2003.

Xiaofeng Jia

Mr. Jia Xiaofeng serves as Joint Company Secretary, Assistant to the Chief Executive Officer and the Chairman of the Group and the Investment Director of the Group of the Company, since 1 April 2016. He is primarily responsible for the Group’s investments, acquisitions and business expansion, corporate finance, corporate governance and overall company secretarial matters of our Group. Mr. Jia first joined BNC Children’s Hospital in March 2009 as an investment manager before working at PricewaterhouseCoopers from April 2010 to November 2011. Mr. Jia worked at Jiahua Likang, our connected person, as a general manager in the investment division from March 2014 to March 2016. Mr. Jia has approximately seven years of experience in corporate finance and investments and approximately twelve years’ experience in the healthcare and medical industry. Prior to initially joining our Group in March 2009, Mr. Jia also worked at The China Care Group Hospital Management and Consulting Co., Ltd. as a partner in their consultancy division since January 2007 to March 2009, where he was primarily responsible for analyzing the Group’s business and financial operations, as well as facilitating and managing investments and development projects in new and existing markets. Mr. Jia obtained an International Master of Business Administration degree from Tsinghua University in Beijing in July 2007 and a bachelor’s degree in clinical medicine from the Capital University of Medical Sciences in Beijing in July 2002.

Lai Shan So

Ms. So Lai Shan is Joint Company Secretary of the Company. Ms. So, an assistant manager of the Listing Services Department of TMF Hong Kong Limited (a global corporate service provider), has more than 8 years of experience in company secretarial field. Ms. So holds a master’s degree in Corporate Governance from The Open University of Hong Kong and is an associate member of the Hong Kong Institute of Chartered Secretaries and the Institute of Chartered Secretaries and Administrators in the United Kingdom.

Qizhi Guo

Mr. Guo Qizhi has been appointed Non-Executive Director of the Company. He is currently a senior partner of CDH Venture and Growth Capital, an investment fund established in 2015 focusing on healthcare, TMT (technology, media and telecommunications) and other innovation-based growth opportunities in the People’s Republic of China (the “PRC”). Mr. Guo joined CDH Equity Investment Management (Tianjin) Co., Ltd. in 2011 and serves as its executive director and manager director of operations, mainly responsible for investments in the medical sector. Mr. Guo also serves as a director of various medical companies in the PRC, including Nanjing Mingji Hospital Co., Ltd. Suzhou Mingji Hospital Co., Ltd. , Mingji (Nanjing) Hospital Management Consulting Co., Ltd. and Zhejiang Dazhong Hospital (Group) Management Co., Ltd. Mr. Guo received a bachelor’s degree in engineering from Northeastern University in Shenyang city, Liaoning province, the PRC in 1994 and a master’s degree in accounting from Liaoning University in the same city in 1998. Before joining CDH Investments in 2011, Mr. Guo had served as a vice president of operations and the chief financial officer of China Resources Sanjiu Medical & Pharmaceutical Co., (listed on the Shenzhen Stock Exchange with stock code 000999), the general manager of strategic investments of the strategic investment department of China Resources (Group) Co., Ltd. the chief financial officer of China Resources (Jilin) Bio-Chemical Co., Ltd.

Yanqing Liang

Ms. Liang Yanqing has been appointed Non-Executive Director of the Company since 18 February 2016. She is primarily responsible for providing strategic advice and guidance on the business development and expansion of our Group. Ms. Liang has more than ten years of experience in business management and investments. Ms. Liang has been a supervisor of Zhonghe Qingrun since January 2005. Prior to that, she served as training specialist at the human resource department of the Guangdong branch of China Mobile Limited between January 2003 and January 2005. She also served as an independent director of VisionChina Media, a media company listed on the NASDAQ Stock Market (NASDAQ: VISN), between February 2006 and April 2016. Ms. Liang obtained her bachelor’s degree in Chinese language and literature education from Harbin Normal University in Harbin, Heilongjiang Province, the PRC in December 1998.

Siye Wang

Mr. Wang Siye serves as Non-Executive Director of the Company, since 18 February 2016. He is primarily responsible for providing strategic advice and guidance on the business development and expansion of our Group. Mr. Wang has over nine years of experience in corporate finance and investments. From June 2013 to August 2016, Mr. Wang served as an executive director of Boyu Capital, an investment firm focused on investing in Greater China. Prior to joining Boyu Capital, Mr. Wang served as an investment manager at CITIC Private Equity Funds Management Co., Ltd. from August 2010 to June 2012 and, prior to that, as an associate at the Investment Banking Department of China International Capital Corporation Co., Ltd. from February 2007 to July 2010. Mr. Wang received his master’s degree in economics from the Hong Kong University of Science and Technology in November 2006, and his bachelor’s degree in computer science from Nanjing University in June 2003.

Lan Zhang

Ms. Zhang Lan serves as Non-Executive Director of the Company, since 18 February 2016. She is primarily responsible for providing strategic advice and guidance on the business development and expansion of our Group. Ms. Zhang has over nine years of experience in private equity and investments. Since September 2013, Ms. Zhang has served as a deputy general manager of the China Development Bank Kaiyuan Equity Investment Fund Management Co., Ltd., an entity controlled by China Development Bank. During her tenure, Ms. Zhang has completed equity investments in multiple medical industry companies and other private equity investments. Prior to joining China Development Bank Kaiyuan Equity Investment Fund Management Co., Ltd., Ms. Zhang served as a vice president at CDH Investments from August 2010 to July 2013. Ms. Zhang received a master’s degree in business administration from the University of Chicago’s Booth School of Business in March 2010, a master’s degree in management from Tsinghua University in Beijing July 2014, and a bachelor’s degree in chemistry from Tsinghua University July 2001.

Yanfu Jiang

Mr. Jiang Yanfu serves as Non-Executive Independent Director of the Company. He was appointed as an independent non-executive Director of the Company in 2016. He is primarily responsible for overseeing and providing independent judgment and analysis to the Board. Mr. Jiang has approximately 14 years of experience in corporate governance and compliance of listed companies. He currently serves as an independent non-executive director of (i) Synthesis Electronic Technology Co., Ltd., a company listed on the Shenzhen Stock Exchange (stock code: 300479), (ii) Jiangxi Bestoo Energy Co., Ltd., a company listed on the National Equities Exchange and Quotations (stock code: 835359) and (iii) Shandong Contact Telecommunication Co., Ltd. a company listed on the National Equities Exchange and Quotations (stock code: 833804). He also served as an independent non-executive director of (i) Zhejiang Reclaim Construction Group Co., Ltd., a company listed on the Shenzhen Stock Exchange (stock code: 002586), from September 2010 to January 2016 and (ii) Toread Holdings Group Co., Ltd., a company listed on the Shenzhen Stock Exchange (stock code: 300005), from June 2011 to September 2014.

Jing Ma

Dr. Ma Jing serves as Non-Executive Independent Director of the Company. She was appointed as an independent non-executive Director of the Company in 2016. She is primarily responsible for overseeing and providing independent judgment and analysis to the Board. Dr. Ma has over 30 years of experience in medical and public health studies. She has been an associate professor at Harvard School of Public Health since 2012 and an associate professor of medicine at Harvard Medical School since 2005. Prior to that, she had held various teaching and research positions at Harvard Medical School, Brigham and Women’s Hospital in Boston, Massachusetts, the U.S. and the University of Minnesota. She is also a member of the American Association for Cancer Research. Dr. Ma received her doctor of philosophy degree in epidemiology from the University of Minnesota in December 1993, her master of public health degree in preventive medicine from Tongji Medical University July 1986 and her bachelor of medicine degree and bachelor of surgery degree in preventive medicine from Wuhan Medical College in Wuhan, Hubei Province, the PRC in August 1983.

Hongbin Sun

Mr. Sun Hongbin serves as Non-Executive Independent Director of the Company. He was appointed as an independent non-executive Director of our Company in 2016. Mr. Sun has served as a director and chief financial officer in MicroPort Scientific Corporation since July 22, 2010. He was also a supervisor of MP Shanghai until July 2010. Mr. Sun has over 10 years of experience in the financial industry. Mr. Sun was the general manager of Otsuka (China) Investment Co., Ltd. from January 2006 to August 2010. From January 2004 to December 2005, he served as a financial deputy director of Otsuka (China) Investment Co., Ltd. From August 1998 to January 2004, Mr. Sun was an assistant manager of the Shanghai office of KPMG. Mr. Sun was a member of the Chinese Institute of Certified Public Accountants and was also a Chartered Financial Analyst. Mr. Sun received his bachelor’s degree in accounting from Shanghai Jiao Tong University in the PRC in 1998.

Guanxiong Wu

Mr. Wu Guanxiong serves as Non-Executive Independent Director of the Company. He was appointed as an independent non-executive Director of the Company in 2016. He is primarily responsible for overseeing and providing independent judgment and analysis to the Board. Mr. Wu has substantial experience in capital markets and securities matters. He is a partner at Tian Yuan Law Firm. Prior to joining Tian Yuan Law Firm in March 1999, he served as a legal advisor at China North Industries Corporation from August 1994 to September 1997. Mr. Wu obtained his bachelor of laws and master of laws in international law from Peking University Law School in July 1994 and January 2000, respectively.

Basic Compensation